SRH AlsterResearch AG: CompuGroup Medical SE confirmed as 'Buy'

Price target unchanged at EUR 88,00

Hamburg (pta011/19.01.2022/10:49 UTC+1)

In a research report published today, the analysts of AlsterResearch have confirmed the rating of CompuGroup Medical SE as 'Buy'. The price target was unchanged at EUR 88,00. The full research report is available at https://www.research-hub.de/companies/research/CompuGroup%20Medical%20SE .

About AlsterResearch: AlsterResearch is an independent equity research house, providing MiFID II-compliant research on mostly German stocks. Reports are available on the digital platform ResearchHub (www.research-hub.de) or via an email subscription free of charge or obligations. AlsterResearch also regularly hosts roadshows, roundtables and conferences with key people in interesting companies. Disclosures: https://research-hub.de/disclaimer

(end)

Emitter:	SRH AlsterResearch AG Himmelstraße 9 22299 Hamburg Germany
Contact Person:	Thomas Wissler
Phone:	+49 40 309 293-52
E-Mail:	t.wissler@alsterresearch.com
Website:	www.alsterresearch.com
ISIN(s):	- (Other)
Stock Exchange(s):	-
Other Stock Exchanges:	-